招商证券(香港)5月21日发布公告。Our DCF-based TP translates into c.1.9x PEG, 75x 2020E PER, justified on Wuxi Bio’s world-class biotech enabling platform and strong growth visibility.
热门推荐
收起
新浪财经公众号
24小时滚动播报最新的财经资讯和视频,更多粉丝福利扫描二维码关注(sinafinance)